Impact of Non-Adherence on Renal and Cardiovascular Outcomes in US Veterans

American Journal of Nephrology

Volumn 42, Issue 2, 2015, Pages 151-157

  Gosmanova, Elvira O ^b   Molnar, Miklos Z ^b   Alrifai, Ahmed ^b   Lu, Jun L ^b   Streja, Elani ^a   Cushman, William C ^c,d   Kalantar Zadeh, Kamyar ^a   Kovesdy, Csaba P ^b,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Nephrology Division Department of Medicine   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^d Departments of Anesthesiology   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Chronic kidney disease; Coronary artery disease; End stage renal disease; Non adherence; Stroke; V15.81 code

Indexed keywords

ANTIHYPERKALEMIC AGENT; ANTIHYPERTENSIVE AGENT;

ADULT; AFRICAN AMERICAN; ANTIHYPERTENSIVE THERAPY; ARTICLE; BODY MASS; CARDIOVASCULAR FUNCTION; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CHRONIC LIVER DISEASE; CHRONIC LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; CORONARY ARTERY DISEASE; CORRELATIONAL STUDY; DEMENTIA; DEPRESSION; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; END STAGE RENAL DISEASE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; ICD-9-CM; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; NEOPLASM; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RACE; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE; VETERAN; AGED; INCIDENCE; KIDNEY FAILURE, CHRONIC; METABOLISM; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RENAL INSUFFICIENCY, CHRONIC; RISK FACTOR; STATISTICS AND NUMERICAL DATA; STROKE; UNITED STATES;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; COHORT STUDIES; CORONARY ARTERY DISEASE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; STROKE; UNITED STATES; VETERANS;

EID: 84942256070     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000440685     Document Type: Article

References (27)

1. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, Lackland DT, LeFevre ML, MacKenzie TD, Ogedegbe O, Smith SC Jr, Svetkey LP, Taler SJ, Townsend RR, Wright JT Jr, Narva AS, Ortiz E: 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the eighth joint national committee (JNC 8). JAMA 2014; 311: 507-520.
2. Staessen JA, Gasowski J, Wang JG, Thijs L, Den Hond E, Boissel JP, Coope J, Ekbom T, Gueyffier F, Liu L, Kerlikowske K, Pocock S, Fagard RH: Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet 2000; 355: 865-872.
3. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Judd SE, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Mackey RH, Magid DJ, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER 3rd, Moy CS, Mussolino ME, Neumar RW, Nichol G, Pandey DK, Paynter NP, Reeves MJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Wong ND, Woo D, Turner MB; American Heart Association Statistics Committee and Stroke Statistics Subcommittee: Heart disease and stroke statistics - 2014 update: a report from the American heart association. Circulation 2014; 129:e28-e292.
4. Ho PM, Bryson CL, Rumsfeld JS: Medication adherence: its importance in cardiovascular outcomes. Circulation 2009; 119: 3028-3035.
5. Adherence to Long Term Therapies: Evidence for Action. Geneva, World Health Organization, 2003. http://wwwwhoint/chp/knowledge/publications/adherence-introductionpdf (accessed on November 20, 2014).
6. Fitz-Simon N, Bennett K, Feely J: A review of studies of adherence with antihypertensive drugs using prescription databases. Ther Clin Risk Manag 2005; 1: 93-106.
7. Mazzaglia G, Mantovani LG, Sturkenboom MC, Filippi A, Trifiro G, Cricelli C, Brignoli O, Caputi AP: Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care. J Hypertens 2005; 23: 2093-2100.
8. Gosmanova EO, Kovesdy CP: Adherence to antihypertensive medications: is prescribing the right pill enough? Nephrol Dial Transplant 2014;pii:gfu330.
9. Gosmanova EO, Lu JL, Streja E, Cushman WC, Kalantar-Zadeh K, Kovesdy CP: Association of medical treatment nonadherence with all-cause mortality in newly treated hypertensive us veterans. Hypertension 2014; 64: 951-957.
10. US Department of Veterans Affairs VIRCVVRUGVPPD, ed 2. Hines, VIReC, 2008.
11. Kovesdy CP, Lott EH, Lu JL, Malakauskas SM, Ma JZ, Molnar MZ, Kalantar-Zadeh K: Hyponatremia, hypernatremia, and mortality in patients with chronic kidney disease with and without congestive heart failure. Circulation 2012; 125: 677-684.
12. Kovesdy CP, Lott EH, Lu JL, Malakauskas SM, Ma JZ, Molnar MZ, Kalantar-Zadeh K: Outcomes associated with microalbuminuria: effect modification by chronic kidney disease. J Am Coll Cardiol 2013; 61: 1626-1633.
13. VIReC Research User Guide: VHA Medical SAS Inpatient Datasets FY 2006-2007. Hines IUSDoVAVIRC, 2007.
14. VIReC: US Department of Veterans Affairs VA Information Resource Center Data Quality Update: Race. Hines IUSDoVA, 2009.
15. Kovesdy CP, Bleyer AJ, Molnar MZ, Ma JZ, Sim JJ, Cushman WC, Quarles LD, Kalantar-Zadeh K: Blood pressure and mortality in U.S. Veterans with chronic kidney disease: a cohort study. Ann Intern Med 2013; 159: 233-242.
16. Kovesdy CP, Lu JL, Molnar MZ, Ma JZ, Canada RB, Streja E, Kalantar-Zadeh K, Bleyer AJ: Observational modeling of strict vs conventional blood pressure control in patients with chronic kidney disease. JAMA Intern Med 2014; 174: 1442-1449.
17. Lu JL, Kalantar-Zadeh K, Ma JZ, Quarles LD, Kovesdy CP: Association of body mass index with outcomes in patients with CKD. J Am Soc Nephrol 2014; 25: 2088-2096.
18. Molnar MZ, Kalantar-Zadeh K, Lott EH, Lu JL, Malakauskas SM, Ma JZ, Quarles DL, Kovesdy CP: Angiotensin-converting enzyme inhibitor, angiotensin receptor blocker use, and mortality in patients with chronic kidney disease. J Am Coll Cardiol 2014; 63: 650-658.
19. Chowdhury R, Khan H, Heydon E, Shroufi A, Fahimi S, Moore C, Stricker B, Mendis S, Hofman A, Mant J, Franco OH: Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences. Eur Heart J 2013; 34: 2940-2948.
20. Degli Esposti L, Saragoni S, Benemei S, Batacchi P, Geppetti P, Di Bari M, Marchionni N, Sturani A, Buda S, Degli Esposti E: Adherence to antihypertensive medications and health outcomes among newly treated hypertensive patients. Clinicoecon Outcomes Res 2011; 3: 47-54.
21. Roy L, White-Guay B, Dorais M, Dragomir A, Lessard M, Perreault S: Adherence to antihypertensive agents improves risk reduction of end-stage renal disease. Kidney Int 2013; 84: 570-577.
22. KDIGO: KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 2013; 3: 1-150.
23. Marcum ZA, Sevick MA, Handler SM: Medication nonadherence: a diagnosable and treatable medical condition. JAMA 2013; 309: 2105-2106.
24. Kettani FZ, Dragomir A, Cote R, Roy L, Berard A, Blais L, Lalonde L, Moreau P, Perreault S: Impact of a better adherence to antihypertensive agents on cerebrovascular disease for primary prevention. Stroke 2009; 40: 213-220.
25. Breekveldt-Postma NS, Penning-van Beest FJ, Siiskonen SJ, Falvey H, Vincze G, Klungel OH, Herings RM: The effect of discontinuation of antihypertensives on the risk of acute myocardial infarction and stroke. Curr Med Res Opin 2008; 24: 121-127.
26. Herttua K, Tabak AG, Martikainen P, Vahtera J, Kivimaki M: Adherence to antihypertensive therapy prior to the first presentation of stroke in hypertensive adults: populationbased study. Eur Heart J 2013; 34: 2933-2939.
27. Foley RN, Collins AJ: The USRDS: what you need to know about what it can and can't tell us about ESRD. Clin J Am Soc Nephrol 2013; 8: 845-851.